iifl-logo-icon 1

Kilitch Drugs (India) Ltd Cash Flow Statement

304.5
(-2.14%)
Nov 8, 2024|03:31:59 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Kilitch Drugs FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Profit before tax

7.5

5.22

19.52

7.15

Depreciation

-1.14

-1.15

-1.2

-1.19

Tax paid

-1.35

-0.76

-4.75

-0.96

Working capital

-1.1

-5.99

6.43

6.49

Other operating items

Operating

3.91

-2.68

19.99

11.49

Capital expenditure

0.43

1

1.67

0.87

Free cash flow

4.34

-1.68

21.66

12.36

Equity raised

277.55

267.55

240.05

218.27

Investing

8.42

-1.57

-0.89

4.22

Financing

2.2

3.15

8.54

0.23

Dividends paid

0

0

0

0.71

Net in cash

292.51

267.44

269.36

235.8

Kilitch Drugs : related Articles

No Record Found

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp